Concepedia

Lauren Horlbogen

LH

3

Publications

93

Citations

3

H-Index

2020

Active since

Affiliations

Pfizer (United States)(Current)

Lauren Horlbogen is an author at Pfizer (United States) specializing in diabetes, medicine, and pharmacology.

Top concepts

Publications per year

2020–2021

3

Publications

3

Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers

Takeshi Miyake, Emi Kimoto, Lina Luo et al. · Clinical Pharmacology & Therapeutics · 2020 · 45 citations · Full text

A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) Biomarker

Lina Luo, Ragu Ramanathan, Lauren Horlbogen et al. · Analytical Chemistry · 2020 · 33 citations

Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in Nigeria

Ogochukwu Amaeze, Heather Eng, Lauren Horlbogen et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2021 · 15 citations · Full text

, , +10

Rows per page

1–3 of 3